Skip to content
Disclosery

Maple-Brown Abbott Ltd: CCI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Maple-Brown Abbott Ltd on CCI, newest first. How the timeline and the estimate are built.

Maple-Brown Abbott Ltd held 1,256,622 CCI shares at 2025-03-31 per its 13F-HR filed 2025-05-13.

the latest 13F is the newest step

  1. period ended2025-03-31
    13F 1,256,622 shares
    Change vs previous 13F +311,354 shares

    8.93% of the 13F portfolio, value $130,988,220.

    13F-HR 0001681596-25-000005 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2024-12-31
    13F 945,268 shares
    Change vs previous 13F +69,150 shares

    10.46% of the 13F portfolio, value $85,792,523.

    13F-HR 0001681596-25-000002 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-09-30
    13F 876,118 shares
    Change vs previous 13F -85,290 shares

    10.31% of the 13F portfolio, value $103,933,878.

    13F-HR 0001681596-24-000016 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-06-30
    13F 961,408 shares
    Change vs previous 13F +66,010 shares

    9.9% of the 13F portfolio, value $93,929,562.

    13F-HR 0001681596-24-000006 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-03-31
    13F/A 895,398 shares
    Change vs previous 13F -13,380 shares

    9.7% of the 13F portfolio, value $94,759,970.

    13F-HR/A 0001681596-24-000012 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2023-12-31
    13F/A 908,778 shares
    Change vs previous 13F -77,510 shares

    10.66% of the 13F portfolio, value $104,682,138.

    13F-HR/A 0001681596-24-000010 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2023-09-30
    13F/A 986,288 shares
    Change vs previous 13F +53,950 shares

    10.41% of the 13F portfolio, value $90,768,085.

    13F-HR/A 0001681596-24-000009 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2023-06-30
    13F/A 932,338 shares
    Change vs previous 13F not available

    11.8% of the 13F portfolio, value $106,230,592.

    13F-HR/A 0001681596-24-000008 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).